| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/11/2014 | US20140256743 Cathepsin cysteine protease inhibitors |
| 09/11/2014 | US20140256738 Use of selective dopamine d4 receptor agonists for treating sexual dysfunction |
| 09/11/2014 | US20140256737 Therapeutic combinations of netupitant and palonosetron |
| 09/11/2014 | US20140256734 Pyridinyl and fused pyridinyl triazolone derivatives |
| 09/11/2014 | US20140256733 Mixed lineage kinase inhibitors and method of treatments |
| 09/11/2014 | US20140256731 Pleuromutilin derivatives for the treatment of diseases mediated by microbes |
| 09/11/2014 | US20140256726 Preservative free bimatoprost and timolol solutions |
| 09/11/2014 | US20140256725 Fsh receptor antagonists |
| 09/11/2014 | US20140256723 Mineralocorticoid receptor antagonists |
| 09/11/2014 | US20140256720 Cancer treatment using bmp inhibitor |
| 09/11/2014 | US20140256719 Pyrrolotriazines as potassium ion channel inhibitors |
| 09/11/2014 | US20140256718 Hydroxymethylaryl-substituted pyrrolotriazines as alk1 inhibitors |
| 09/11/2014 | US20140256717 Macrocyclic compounds as protein kinase inhibitors |
| 09/11/2014 | US20140256715 Novel Oxazine Derivatives and their use in the Treatment of Disease |
| 09/11/2014 | US20140256709 Cns pharmaceutical compositions and methods of use |
| 09/11/2014 | US20140256706 Bet bromodomain inhibitors and therapeutic methods using the same |
| 09/11/2014 | US20140256705 Bromodomain inhibitors |
| 09/11/2014 | US20140256702 Neprilysin inhibitors |
| 09/11/2014 | US20140256700 Carbazole compounds useful as bromodomain inhibitors |
| 09/11/2014 | US20140256693 Pyrrolo [1,2-c] imidazole derivatives for use in the prophylaxis or treatment of cancer which is refractory to known cancer therapies |
| 09/11/2014 | US20140256692 Composition and Method for Alleviation of Pain and Inflammation |
| 09/11/2014 | US20140256691 Combinations of akt inhibitor compounds and abiraterone, and methods of use |
| 09/11/2014 | US20140256690 Contraceptive method |
| 09/11/2014 | US20140256689 Petroleum jelly-free unguent compositions comprising vitamin d compounds and optionally steroidal anti-inflammatory agents |
| 09/11/2014 | US20140256688 Topical compositions and methods of treatment of anorectal disorders |
| 09/11/2014 | US20140256683 Treating disease using compositions for oral administration of zoledronic acid or related compounds |
| 09/11/2014 | US20140256682 Co-administration of steroids and zoledronic acid to prevent and treat osteoarthritis |
| 09/11/2014 | US20140256681 Co-administration of steroids and Zoledronic Acid to prevent and treat osteoarthritis |
| 09/11/2014 | US20140256680 Combination therapy of hsp90 inhibitors with braf inhibitors |
| 09/11/2014 | US20140256675 Ophthalmic compositions and methods for treating eyes |
| 09/11/2014 | US20140256674 Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof |
| 09/11/2014 | US20140256672 Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions or inflammatory disease using low sulphate fucans |
| 09/11/2014 | US20140256671 Method for improving executive function |
| 09/11/2014 | US20140256667 Novel treatments for actinic keratoses |
| 09/11/2014 | US20140256665 Aminoglycoside and Azole Compositions and Methods |
| 09/11/2014 | US20140256664 Compositions and methods for a mycobacterium tuberculosis drug susceptibility test |
| 09/11/2014 | US20140256663 Amphotericin Analogous Compounds and Pharmaceutical Compositions Containing Them |
| 09/11/2014 | US20140256662 Administration of avermectin/milbemycin compounds for the treatment of ophthalmic pathologies |
| 09/11/2014 | US20140256661 Pharmaceutical compositions for rectal administration |
| 09/11/2014 | US20140256656 D-mannose contraceptives |
| 09/11/2014 | US20140256655 Products and methods for aortic abdominal aneurysm |
| 09/11/2014 | US20140256647 Kits and methods for the treatment of cancer using gliadin peptides |
| 09/11/2014 | US20140256644 Treatment of Muscular Conditions and Muscular Dystrophies |
| 09/11/2014 | US20140256643 Peptides and compositions for treatment of joint damage |
| 09/11/2014 | US20140256632 Methods useful in the treatment of bone resorption diseases |
| 09/11/2014 | US20140256627 Methods of delivering pharmaceutical agents |
| 09/11/2014 | US20140256624 Pharmaceutical composition, methods for treating and uses thereof |
| 09/11/2014 | US20140256619 Use of avermectin derivative for increasing bioavailability and efficacy of macrocylic lactones |
| 09/11/2014 | US20140256616 Modified green tea polyphenol formulations |
| 09/11/2014 | US20140256015 Caged compound which can be photoactivated selectively for cell types |
| 09/11/2014 | US20140255528 Compositions and methods for treating, inhibiting the onset, and slowing the progression of erectile dysfunction including naturally occurring age related erectile dysfunction |
| 09/11/2014 | US20140255526 Use of a ginseng extract to prevent and treat alopecia areata |
| 09/11/2014 | US20140255524 Alpha-gpc dietary supplements for weight loss and/or increasing or maintaining lean body mass |
| 09/11/2014 | US20140255522 Topical compositions and methods of treatment of anorectal and genital disorders |
| 09/11/2014 | US20140255521 Topical compositions and methods of treatment of topical disorders |
| 09/11/2014 | US20140255519 Electrolyte supplement and method of use |
| 09/11/2014 | US20140255517 Managing post-traumatic stress disorder |
| 09/11/2014 | US20140255512 Composition useful for the prevention or reduction of the progression of prostate cancer |
| 09/11/2014 | US20140255511 Accelerating muscle recovery after immobilization-induced muscle atrophy |
| 09/11/2014 | US20140255509 Composition |
| 09/11/2014 | US20140255505 Pazopanib Formulation |
| 09/11/2014 | US20140255503 Pharmaceutical composition of omeprazole |
| 09/11/2014 | US20140255501 Novel Preparation Of An Enteric Release System |
| 09/11/2014 | US20140255499 Method of Forming Fine Particles of a Drug Substance |
| 09/11/2014 | US20140255498 Pharmaceutical nanosuspension |
| 09/11/2014 | US20140255497 Organic Compounds |
| 09/11/2014 | US20140255494 Novel Formulation of Indomethacin |
| 09/11/2014 | US20140255492 Fine dry particulate adenosine compositions and topical formulations including the same |
| 09/11/2014 | US20140255491 Method and System For the Treatment of Chronic Obstructive Pulmonary Disease With Nebulized Anticholinergic Administrations |
| 09/11/2014 | US20140255488 Long acting sustained-release formulation containing dopamine receptor agonist and the preparation method thereof |
| 09/11/2014 | US20140255487 Dosage form for insertion into the mouth |
| 09/11/2014 | US20140255486 Coated Tablet Formulation and Method |
| 09/11/2014 | US20140255484 Modified release pharmaceutical compositions of dexlansoprazole |
| 09/11/2014 | US20140255480 Pharmaceutical formulation of nanonized fenofibrate |
| 09/11/2014 | US20140255479 Pharmaceuticals for Oral Delivery |
| 09/11/2014 | US20140255477 Compositions and Methods for Delivery of High-Affinity Oxygen Binding Agents to Tumors |
| 09/11/2014 | US20140255475 Method of lyophilizing liposomes |
| 09/11/2014 | US20140255474 Composition for Treatment of Inflammatory Disorders |
| 09/11/2014 | US20140255473 Steroid hormone delivery systems and methods of preparing the same |
| 09/11/2014 | US20140255472 Pegylated liposomes for delivery of immunogen-encoding rna |
| 09/11/2014 | US20140255471 Method of treating brain tumors |
| 09/11/2014 | US20140255466 Composition for enhancing transdermal absorption of drug and patch preparation |
| 09/11/2014 | US20140255463 Sweet tart energy tablet |
| 09/11/2014 | US20140255458 Injectable bulking compositions |
| 09/11/2014 | US20140255433 Pde5 inhibitor compositions and methods for immunotherapy |
| 09/11/2014 | US20140255432 Silvestrol, silvestrol analogs and uses thereof |
| 09/11/2014 | US20140255428 Quinazoline Inhibitors of activating mutant forms of Epidermal Growth Factor Receptor |
| 09/11/2014 | US20140255427 Combination therapy with an anti - cd19 antibody and a nitrogen mustard |
| 09/11/2014 | US20140255426 Wnt pathway inhibitors for treating viral infections |
| 09/11/2014 | US20140255421 Methods and Compositions for Treating Polyps |
| 09/11/2014 | US20140255420 Combination Therapy of Beta-Glycolipids and Antibodies for the Treatment of Immune-Related Disorders |
| 09/11/2014 | US20140255413 Combination therapy for neoplasia treatment |
| 09/11/2014 | US20140255408 Bispecific EGFR/C-Met Antibodies |
| 09/11/2014 | US20140255404 Pulmonary hypertension |
| 09/11/2014 | US20140255402 Method of treating leukemia in a mammal |
| 09/11/2014 | US20140255394 Method of Treating Colorectal Cancer |
| 09/11/2014 | US20140255392 Substituted imidazopyridines and intermediates thereof |
| 09/11/2014 | US20140255390 Method of Treating Rheumatoid Arthritis With An Anti-IL-6R Antibody |
| 09/11/2014 | US20140255386 Microrna modulators and method for identifying and using the same |
| 09/11/2014 | US20140255381 Glucosylceramide synthase inhibitors |